| |
Wednesday December 17, 7:58 am Eastern Time
Company Press Release
SOURCE: IVAX Corporation
IVAX Announces Generic Drug Approval for Verapamil; FDA Approval Completes IVAX's Verapamil Line
MIAMI, Dec. 17 /PRNewswire/ -- IVAX Corporation (Amex: IVX - news) today announced that the United States Food and Drug Administration approved an Abbreviated New Drug Application for the generic pharmaceutical product verapamil HCl ER in 120 mg tablets. Verapamil is indicated for the management of hypertension, and is the generic equivalent of Knoll Pharmaceutical Company's Isoptin(R) SR and G.D. Searle & Co.'s Calan(R) SR. The product will be marketed by IVAX's wholly owned subsidiary, Zenith Goldline Pharmaceuticals, Inc. and sales have commenced. Zenith Goldline now has authority to manufacture and market all three dosage strengths of verapamil extended release tablets.
IVAX Corporation, headquartered in Miami, Florida, is a holding company with core subsidiaries engaged primarily in the research, development, manufacture and marketing of generic and branded pharmaceuticals.
SOURCE: IVAX Corporation
------------------------------------------------------------------------ |
|
